Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monika Wierdl

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Current Hematology Reports|July 13, 2005
Update on gene therapy approaches for cancerMonika Wierdl, Philip M Potter
British Journal of Pharmacology|July 17, 2016
Tumour-selective targeting of drug metabolizing enzymes to treat metastatic cancerMonika Wierdl, Lyudmila Tsurkan, M Jason Hatfield, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 30, 2008
Modifications of human carboxylesterase for improved prodrug activationJason M Hatfield, Monika Wierdl, Randy M Wadkins, et al.
Biochemistry|February 18, 2004
Molecular modeling of CPT-11 metabolism by carboxylesterases (CEs): use of pnb CE as a modelMonika Wierdl, Christopher L Morton, Nathan K Nguyen, et al.
Molecular Cancer Therapeutics|September 21, 2006
Intracellular inhibition of carboxylesterases by benzil: modulation of CPT-11 cytotoxicityJanice L Hyatt, Lyudmila Tsurkan, Monika Wierdl, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 23, 2003
p53-mediated regulation of expression of a rabbit liver carboxylesterase confers sensitivity to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11)Monika Wierdl, Christopher L Morton, Linda C Harris, et al.
Molecular Pharmacology|July 19, 2003
Carboxylesterase-mediated sensitization of human tumor cells to CPT-11 cannot override ABCG2-mediated drug resistanceMonika Wierdl, Amelia Wall, Christopher L Morton, et al.
Journal of Molecular Modeling|December 1, 2011
Global and local molecular dynamics of a bacterial carboxylesterase provide insight into its catalytic mechanismXiaozhen Yu, Sara C Sigler, Delwar Hossain, et al.
Biological Chemistry|January 1, 2008
Evaluation of the 'side door' in carboxylesterase-mediated catalysis and inhibitionTimothy M Streit, Abdolsamad Borazjani, Shellaine E Lentz, et al.
Cancer Chemotherapy and Pharmacology|June 2, 2018
Targeting ALK in pediatric RMS does not induce antitumor activity in vivoMonika Wierdl, Lyudmila Tsurkan, Liying Chi, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Hematology Reports|July 13, 2005
Update on gene therapy approaches for cancerMonika Wierdl, Philip M Potter
British Journal of Pharmacology|July 17, 2016
Tumour-selective targeting of drug metabolizing enzymes to treat metastatic cancerMonika Wierdl, Lyudmila Tsurkan, M Jason Hatfield, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 30, 2008
Modifications of human carboxylesterase for improved prodrug activationJason M Hatfield, Monika Wierdl, Randy M Wadkins, et al.
Biochemistry|February 18, 2004
Molecular modeling of CPT-11 metabolism by carboxylesterases (CEs): use of pnb CE as a modelMonika Wierdl, Christopher L Morton, Nathan K Nguyen, et al.
Molecular Cancer Therapeutics|September 21, 2006
Intracellular inhibition of carboxylesterases by benzil: modulation of CPT-11 cytotoxicityJanice L Hyatt, Lyudmila Tsurkan, Monika Wierdl, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 23, 2003
p53-mediated regulation of expression of a rabbit liver carboxylesterase confers sensitivity to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11)Monika Wierdl, Christopher L Morton, Linda C Harris, et al.
Molecular Pharmacology|July 19, 2003
Carboxylesterase-mediated sensitization of human tumor cells to CPT-11 cannot override ABCG2-mediated drug resistanceMonika Wierdl, Amelia Wall, Christopher L Morton, et al.
Journal of Molecular Modeling|December 1, 2011
Global and local molecular dynamics of a bacterial carboxylesterase provide insight into its catalytic mechanismXiaozhen Yu, Sara C Sigler, Delwar Hossain, et al.
Biological Chemistry|January 1, 2008
Evaluation of the 'side door' in carboxylesterase-mediated catalysis and inhibitionTimothy M Streit, Abdolsamad Borazjani, Shellaine E Lentz, et al.
Cancer Chemotherapy and Pharmacology|June 2, 2018
Targeting ALK in pediatric RMS does not induce antitumor activity in vivoMonika Wierdl, Lyudmila Tsurkan, Liying Chi, et al.
Pageof 2